| 36222594 | MIF is a common genetic determinant of COVID-19 symptomatic infection and severity. | QJM | 2023 |
| 36893070 | Occupational Risk Factors for SARS-CoV-2 Seropositivity in Healthcare Workers: Results of a Longitudinal Cohort. | J Occup Environ Med | 2023 |
| 35028957 | Severe asthma and death in a worker using methylene diphenyl diisocyanate MDI asthma death. | Am J Ind Med | 2022 |
| 35839242 | Glutathione reactivity with aliphatic polyisocyanates. | PLoS One | 2022 |
| 36550362 | Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein. | Sci Rep | 2022 |
| 36054278 | Changes Over Time in COVID-19 Incidence, Vaccinations, Serum Spike IgG, and Viral Neutralizing Potential Among Individuals From a North American Gaming Venue: December 2020-August 2021. | J Occup Environ Med | 2022 |
| 35041700 | Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses. | PLoS One | 2022 |
| 34145437 | Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19. | Nat Med | 2021 |
| 34647343 | Reply to letter to the editor concerning Gui et al. Inception cohort study of workers exposed to toluene diisocyanate at a polyurethane foam factory. | Am J Ind Med | 2021 |
| 34499652 | Immunogenic amino acid motifs and linear epitopes of COVID-19 mRNA vaccines. | PLoS One | 2021 |
| 34460832 | Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel. | PLoS One | 2021 |
| 34133415 | Human IgG and IgA responses to COVID-19 mRNA vaccines. | PLoS One | 2021 |
| 32302507 | Molecular Characterization and Experimental Utility of Monoclonal Antibodies with Specificity for Aliphatic Di- and Polyisocyanates. | Monoclon Antib Immunodiagn Immunother | 2020 |
| 32101465 | Analysis of Lung Gene Expression Reveals a Role for Cl<sup>-</sup> Channels in Diisocyanate-induced Airway Eosinophilia in a Mouse Model of Asthma Pathology. | Am J Respir Cell Mol Biol | 2020 |
| 33398304 | Kinetics of antibody responses dictate COVID-19 outcome. | medRxiv | 2020 |
| 30395213 | Development and Validation of LC-MS-MS Assay for the Determination of the Emerging Alkylating Agent Laromustine and Its Active Metabolite in Human Plasma. | J Chromatogr Sci | 2019 |
| 31143884 | LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate. | EC Pharmacol Toxicol | 2019 |
| 30724074 | Dilysine-Methylene Diphenyl Diisocyanate (MDI), a Urine Biomarker of MDI Exposure? | Chem Res Toxicol | 2019 |
| 28629263 | Mass spectrometry-based analysis of murine bronchoalveolar lavage fluid following respiratory exposure to 4,4'-methylene diphenyl diisocyanate aerosol. | Xenobiotica | 2018 |
| 28489470 | Reaction products of hexamethylene diisocyanate vapors with "self" molecules in the airways of rabbits exposed via tracheostomy. | Xenobiotica | 2018 |
| 29175138 | Polymerization of hexamethylene diisocyanate in solution and a 260.23Â m/z [M+H]<sup>+</sup> ion in exposed human cells. | Anal Biochem | 2018 |
| 27440490 | Population pharmacokinetic (PK) analysis of laromustine, an emerging alkylating agent, in cancer patients. | Xenobiotica | 2017 |
| 28124752 | Automation of sample preparation for mass cytometry barcoding in support of clinical research: protocol optimization. | Anal Bioanal Chem | 2017 |
| 27784537 | Corrigendum to "Identification of novel reaction products of methylene-biS-phenylisocyanate ("MDI") with oxidized glutathione in aqueous solution and also during incubation of MDI with a murine hepatic S9 fraction" [Toxicol. In vitro (2016) 97-104]. | Toxicol In Vitro | 2017 |
| 27919805 | UPLC-MS for metabolomics: a giant step forward in support of pharmaceutical research. | Drug Discov Today | 2017 |
| 26847541 | Mass cytometry moving forward in support of clinical research: advantages and considerations. | Bioanalysis | 2016 |
| 26678254 | In vitro cleavage of diisocyanate-glutathione conjugates by human gamma-glutamyl transpeptidase-1. | Xenobiotica | 2016 |
| 27124286 | The influence of diisocyanate antigen preparation methodology on monoclonal and serum antibody recognition. | J Occup Environ Hyg | 2016 |
| 27453132 | Identification of novel reaction products of methylene-bis-phenylisocyanate ("MDI") with oxidized glutathione in aqueous solution and also during incubation of MDI with a murine hepatic S9 fraction. | Toxicol In Vitro | 2016 |
| 27323800 | Progress in automation of mass cytometry barcoding for drug development. | Bioanalysis | 2016 |
| 27278961 | Biotransformation and Rearrangement of Laromustine. | Drug Metab Dispos | 2016 |
| 26690039 | Immunochemical detection of the occupational allergen, methylene diphenyl diisocyanate (MDI), in situ. | J Immunol Methods | 2016 |
| 25798740 | Metabolic disposition of the anti-cancer agent [(14)C]laromustine in male rats. | Xenobiotica | 2015 |
| 26092491 | Impact of recent innovations in the use of mass cytometry in support of drug development. | Drug Discov Today | 2015 |
| 25635619 | Glutathione reaction products with a chemical allergen, methylene-diphenyl diisocyanate, stimulate alternative macrophage activation and eosinophilic airway inflammation. | Chem Res Toxicol | 2015 |
| 25266741 | Inception cohort study of workers exposed to toluene diisocyanate at a polyurethane foam factory: initial one-year follow-up. | Am J Ind Med | 2014 |
| 23295252 | Molecular determinants of humoral immune specificity for the occupational allergen, methylene diphenyl diisocyanate. | Mol Immunol | 2013 |
| 23791970 | Connecting glutathione with immune responses to occupational methylene diphenyl diisocyanate exposure. | Chem Biol Interact | 2013 |
| 23178851 | Hexamethylene diisocyanate (HDI) vapor reactivity with glutathione and subsequent transfer to human albumin. | Toxicol In Vitro | 2013 |
| 22206939 | Vapor conjugation of toluene diisocyanate to specific lysines of human albumin. | Anal Biochem | 2012 |
| 22449630 | Biomonitoring Hexamethylene diisocyanate (HDI) exposure based on serum levels of HDI-specific IgG. | Ann Occup Hyg | 2012 |
| 21414210 | Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses. | J Occup Med Toxicol | 2011 |
| 21806041 | Toluene diisocyanate reactivity with glutathione across a vapor/liquid interface and subsequent transcarbamoylation of human albumin. | Chem Res Toxicol | 2011 |
| 21978852 | Pathogenesis and disease mechanisms of occupational asthma. | Immunol Allergy Clin North Am | 2011 |
| 20123080 | Antigenic changes in human albumin caused by reactivity with the occupational allergen diphenylmethane diisocyanate. | Anal Biochem | 2010 |
| 20545707 | Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease? | Clin Exp Allergy | 2010 |
| 18498542 | Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI-albumin conjugates. | Clin Exp Allergy | 2008 |
| 17351466 | Developments in laboratory diagnostics for isocyanate asthma. | Curr Opin Allergy Clin Immunol | 2007 |
| 17581205 | Diisocyanate conjugate and immunoassay characteristics influence detection of specific antibodies in HDI-exposed workers. | Clin Exp Allergy | 2007 |
| 17656675 | Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates. | Am J Respir Crit Care Med | 2007 |